Suscribirse

Thalamic deep brain stimulation for post-traumatic neuropathic limb pain: Efficacy at five years’ follow-up and effective volume of activated brain tissue - 23/07/21

Doi : 10.1016/j.neuchi.2021.06.006 
V. Abreu a, b, , R. Vaz b, c, d, C. Chamadoira c, V. Rebelo e, C. Reis f, F. Costa f, J. Martins g, M.J. Gillies h, T.Z. Aziz b, h, E.A.C. Pereira b, i
a Department of Neuroradiology. Centro Hospitalar Universitário do Porto, Porto, Portugal 
b Faculdade de Medicina da Universidade do Porto, Portugal 
c Department of Neurosurgery. Centro Hospitalar Universitário São João, Porto, Portugal 
d Neurociences Unity Hospital Cuf, Porto, Portugal 
e Pain Unit. Centro Hospitalar Universitário São João, Porto, Portugal 
f Department of Neuroradiology. Centro Hospitalar Universitário São João, Porto, Portugal 
g Medtronic, Portugal 
h Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom 
i Neurosciences Research Centre, Institute of Molecular and Clinical Neurosciences, St. George's, University of London, London, United Kingdom 

Corresponding author. Department of Neuroradiology. Centro Hospitalar Universitário do Porto, Portugal, Rua Professor Antão de Almeida Garrett, no 76, 12° andar, habitação 2, 4250-041 Porto, Portugal.Department of Neuroradiology. Centro Hospitalar Universitário do Porto, PortugalRua Professor Antão de Almeida Garrett, no 76, 12° andar, habitação 2Porto4250-041Portugal
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Friday 23 July 2021
This article has been published in an issue click here to access

Abstract

Chronic neuropathic pain affects 7%–10% of the population. Deep brain stimulation (DBS) has shown variable but promising results in its treatment. This study prospectively assessed the long-term effectiveness of DBS in a series of patients with chronic neuropathic pain, correlating clinical results with neuroimaging. Sixteen patients received 5 years’ post-surgical follow-up in a single center. Six had phantom limb pain after amputation and 10 had deafferentation pain after traumatic brachial plexus injury. Patient-reported outcome measures were completed before and after surgery, using VAS, UWNPS, BPI and SF-36 scores. Neuroimaging evaluated electrode location and effective volumes of activated tissue (VAT). Two subgroups were created based on the percentage of VAT superimposed upon the ventroposterolateral thalamic nucleus (eVAT), and clinical outcomes were compared. Analgesic effect was assessed at 5 years and compared to preoperative pain, with an improvement on VAS of 76.4% (p=0.0001), on UW-NPS of 35.2% (p=0.3582), on BPI of 65.1% (p=0.0505) and on SF-36 of 5% (p=0.7406). Eight patients with higher eVAT showed improvement on VAS of 67.5% (p=0.0017) while the remaining patients, with lower eVAT, improved by 50.6% (p=0.03607). DBS remained effective in improving chronic neuropathic pain after 5 years. While VPL-targeting contributes to success, analgesia is also obtained by stimulating surrounding posterior ventrobasal thalamic structures and related spinothalamocortical tracts.

El texto completo de este artículo está disponible en PDF.

Esquema


© 2021  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.